ADIM
CHRW icon

Alpha DNA Investment Management’s C.H. Robinson CHRW Stock Holding History

Alpha DNA Investment Management’s Portfolio CHRW Stock Details CHRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,624
Closed -$496K – 211
2024
Q2 		$496K Buy
+5,624
New +$449K 0.19% 109
2022
Q3 		– Sell
-10,071
Closed -$1.02M – 160
2022
Q2 		$1.02M Buy
+10,071
New +$1.05M 0.87% 46

Other funds holding CHRW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's CHRW Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of C.H. Robinson (CHRW) in Q3 2024, closing a stake of 5,624 shares — an estimated $496K sold.

Alpha DNA Investment Management first reported a position in CHRW in Q2 2022 and held it in 2 quarters. The position peaked at $1.02M in Q2 2022. 642 funds tracked by Wall St. Rank hold CHRW as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining C.H. Robinson position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,624 C.H. Robinson shares in Q3 2024, an estimated $496K.
  • Alpha DNA Investment Management first reported a position in C.H. Robinson in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's C.H. Robinson position peaked at $1.02M in Q2 2022.
  • 642 funds tracked by Wall St. Rank held C.H. Robinson as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.